ASHLEY ANN LIMITED

Company number SC098823 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

Financial Health Score: C+

Explanation: While the patient is not in critical condition, it has suffered a severe shock to its system. The dramatic drop in profitability and the erosion of net assets are concerning symptoms of an acute illness. However, a previously strong constitution (robust prior year equity and cash reserves) and an unqualified audit report regarding its going concern status keep it out of the intensive care unit. The business requires close monitoring and strict adherence to its new financial treatment plan.


Key Vital Signs

  • EBITDA Pulse (Profitability): Weak and thready. EBITDA plummeted by 87% from £574,370 in 2024 to just £74,014 in 2025. On a prior year turnover of roughly £20.2 million, this represents an EBITDA margin of roughly 0.36% for 2025—a dangerously thin margin that leaves the business highly vulnerable to further shocks.
  • Net Asset Weight (Equity): Losing mass. Net assets decreased by roughly 22%, dropping from £2,088,158 to £1,628,870. This represents a significant bleed of retained earnings, reducing the financial cushion available to the business.
  • Cash Circulation (Liquidity): Previously strong, but needs monitoring. As of the 2024 year-end, the company had over £1 million in cash (£1,015,924). While the 2025 cash position isn't explicitly detailed in the summary, the auditor's clean bill of health regarding going concern suggests the patient still has sufficient liquidity to meet its immediate obligations.
  • Dividend Reflexes: Absent. The directors have not recommended a dividend, which is the correct physiological response—conserving energy (cash) rather than expending it during a period of illness.

Diagnosis

Acute Margin Compression Syndrome with Underlying Structural Resilience

The financial data reveals that Ashley Ann Limited has contracted a severe case of margin compression. The external "pathogens"—sustained material cost inflation and a contraction in consumer spending on home improvements—have aggressively attacked the company's profitability. The drop from a healthy EBITDA of £574k to a fragile £74k indicates that the business was unable to pass these increased costs onto the consumer quickly enough, resulting in a severe profit hemorrhage.

However, this is not a terminal diagnosis. The patient has a strong underlying constitution. Having traded since 1986, the business has built up substantial reserves (over £1.6m in net assets), which act as a robust immune system, preventing the short-term shock from turning into a solvency crisis. The independent auditor has confirmed that there are no material uncertainties regarding the company's ability to continue as a going concern.

The management has identified the illness and has begun prescribing treatment, noting a "comprehensive cost review" to reduce the core operating cost base. Furthermore, early signs of recovery are noted, with improving sales and new housing contracts acting as a healthy intake of new revenue.


Recommendations

  1. Intensive Cash Flow Management: With profitability severely diminished, cash is the lifeblood keeping the patient stable. Management must rigorously monitor working capital, enforce strict credit terms (as noted in their strategic report), and delay any non-essential capital expenditure until margins recover.
  2. Nutritional Support via New Contracts: The strategic report notes newly secured housing contracts and new trade customers. Management must ensure these contracts are priced to reflect current inflationary pressures. Taking on high-volume, low-margin work right now could do more harm than good.
  3. Monitor the Cost Diet: The comprehensive cost review must be an ongoing discipline, not a one-time exercise. Fixed costs need to be flexed to the new, lower revenue base to ensure the business can breathe comfortably if the market takes longer to recover.
  4. Regular Check-ups: Given the severity of the drop in profitability, management should implement monthly or quarterly rolling forecasts rather than relying on annual projections. This will allow them to spot any relapse in financial health before it becomes an emergency.

Perspective: Financial Health Diagnostician · Model: glm-5.1 · Generated 10 September 2026